Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 14
- Countries
- 0
Exclusivity
Patents and exclusivities
14| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10912765 | UPNEEQoxymetazoline hydrochloride | use | Aug 2031 |
| 8357714 | UPNEEQoxymetazoline hydrochloride | use | Aug 2031 |
| 9867808 | UPNEEQoxymetazoline hydrochloride | use | Aug 2031 |
| 10799481 | UPNEEQoxymetazoline hydrochloride | use | Dec 2039 |
| 10814001 | UPNEEQoxymetazoline hydrochloride | product | Dec 2039 |
| 10898573 | UPNEEQoxymetazoline hydrochloride | product | Dec 2039 |
| 10940138 | UPNEEQoxymetazoline hydrochloride | use | Dec 2039 |
| 11103482 | UPNEEQoxymetazoline hydrochloride | product | Dec 2039 |
| 11311515 | UPNEEQoxymetazoline hydrochloride | product | Dec 2039 |
| 11324722 | UPNEEQoxymetazoline hydrochloride | use | Dec 2039 |
| 11541036 | UPNEEQoxymetazoline hydrochloride | product | Dec 2039 |
| 11701343 | UPNEEQoxymetazoline hydrochloride | use | Dec 2039 |
| 12605363 | UPNEEQoxymetazoline hydrochloride | product | Dec 2039 |
| 12648930 | UPNEEQoxymetazoline hydrochloride | use | Dec 2039 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| UPNEEQ | Oxymetazoline hydrochloride ophthalmic | solution/ drops, ophthalmic | 73687-062NDA |
Enquiry
Common questions
- Is RVL Pharmaceuticals, Inc. FDA approved?
- RVL Pharmaceuticals, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does RVL Pharmaceuticals, Inc. make?
- 1 product is listed under RVL Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as solution/ drops. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.